+Search query
-Structure paper
Title | Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 62, Page 4979-4990, Year 2019 |
Publish date | Dec 5, 2018 (structure data deposition date) |
Authors | Wang, Z. / Jiang, X. / Zhang, X. / Tian, G. / Yang, R. / Wu, J. / Zou, X. / Liu, Z. / Yang, X. / Wu, C. ...Wang, Z. / Jiang, X. / Zhang, X. / Tian, G. / Yang, R. / Wu, J. / Zou, X. / Liu, Z. / Yang, X. / Wu, C. / Shi, J. / Li, J. / Suo, J. / Wang, Y. / Zhang, R. / Xu, Z. / Gong, X. / He, Y. / Zhu, W. / Aisa, H.A. / Jiang, H. / Xu, Y. / Shen, J. |
External links | J. Med. Chem. / PubMed:31021628 |
Methods | X-ray diffraction |
Resolution | 2.155 Å |
Structure data | PDB-6iwi: |
Chemicals | ChemComp-MG: ChemComp-ZN: ChemComp-B0C: ChemComp-HOH: |
Source |
|
Keywords | HYDROLASE / PDE5A / Inhibitor / Complex structure |